Related Experiment Videos
Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management
A A Brandes1, L M Pasetto, F Lumachi
1Department of Medical Oncology, Gastroenterological Sciences, Azienda Ospedale Università, Padova, Italy. brandes@ux1.unipd.it
Journal of Neuro-Oncology
|August 10, 2000
Abstract:
Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.